Articles
-
Early Licensure Of A Breakthrough Cancer Drug Gives Hope To Patients
6/15/2020
No clinical supply request could be a higher priority than that of a physician urgently seeking an investigational cancer drug for a patient who has exhausted all treatment options.
-
Managing Clinical Ancillary Supplies At Global Scale
12/26/2019
Clinical ancillary management expertise helps biopharma company oversee a large, global trial from start through finish.
-
Minimizing Errors And Saving Time In Drug Receipt Processes
3/20/2019
The speed-accuracy trade-off is a well-known phenomenon in psychology for processes requiring human input: the faster you go, the more likely it is that errors will be introduced into the system.
-
Off-Site Storage Of Biological Specimens And Biologics For Risk Mitigation
2/11/2019
Choosing an offsite storage facility means asking the right questions to determine if the storage provider has the appropriate risk mitigation infrastructure in place, beginning with a realistic threat assessment.
-
How An Outsourcing Partner Can Deliver Efficient Serialization Solutions
11/5/2018
Are you serialization-ready? Failure to comply could result in penalties and the inability to sell your un-serialized products.
-
Reduce Cost And Effort When Servicing Clinical Trials In Canada
2/6/2018
Contracting an in-country clinical depot helps bring costs and timelines under control.
-
Your Trusted Packaging And Serialization Partner
2/6/2018
How your manufacturing, packaging, serialization, and clinical distribution can benefit with a contract partner.
-
Temperature Control Distribution EU Product Launch
1/10/2018
A US biopharmaceutical company approached Almac to assist with the EU product launch of their high value, temperature sensitive, orphan drug product.
-
What Does The Deferment In The DSCSA Deadline Enforcement Mean For You?
9/12/2017
Determine your plan now for serialization readiness to put the worries of DSCSA costs and timelines behind you and patient safety back where it belongs — at the forefront.
-
Understanding And Delivering Your EU Orphan Drug Launch
8/25/2017
Although the European marketplace presents a significant opportunity for innovative orphan drug companies to meet unmet patient needs, launching your drug product can present a real challenge.